Church RF, Meeker-O'Connell WA. A new era of GCP accountability: FDA
aggressively targets clinical trial oversight and data integrity. FDLI
Update 2009; 4: 38-42.
Meeker-O'Connell WA. Institutional review boards: current compliance
trends and emerging models. J Healthcare Compliance 2007; 9(2):5-10.
Garcia S, Abu-Qare A, Meeker-O'Connell W, Borton A, Abou-Donia M.
Methyl Parathion: A Review of Health Effects. J Toxicol
Env Health Part B: Critical Reviews 2003; 6(2):185 -
Frothingham R, Meeker-O'Connell WA. Genetic diversity in the Mycobacterium
tuberculosis complex based on variable numbers of tandem DNA repeats. Microbiol
Frothingham R, Meeker-O'Connell WA, Talbot EAS, George JW, Kreuzer KN.
Identification, cloning, and expression of the Escherichia coli pyrazinamidase
and nicotinamidase gene, pncA. Antimicrob Agents Chemother 1996;40:1426-1431.
Wu S, Meeker WA, Wiener JR, Berchuck A, Bast RC Jr, Boyer CM. Gynecol Oncol